Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,326
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,859
Class I recallsReasonable probability of serious health consequences
24,440
Class II recallsTemporary or medically reversible health consequences
2,900
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,095 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/winco-foods-llc-issues-allergy-alert-undeclared-sesame-hoagie-rollsPublished October 22, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,440
Class I9,859
Class III2,900
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,440
Class I9,859
Class III2,900
Not Yet Classified2

Showing 5,281–5,300 of 17,449 recalls

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

MVASI, (bevacizumab-awwb), Sterile Ophthalmic Solution for Injection, 3.25mg/0.13mL (25 mg/mL) 0.13 mL per syringe, Dose: 1.25mg/0.05mL, Single Use Syringe For Intraocular Injection, Edge Pharma, LLC, 856 Hercules Dr. Colchester, VT 05446, NDC 05446-1661-13

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Neostigmine methylsulfate, 5 mg/5mL (1 mg/mL), 5 mL per syringe, Single Use Syringe for IV or IM Injection, Edge Pharma, LLC, 856 Hercules Dr. Colchester, VT 05446, NDC 05446-1549-05

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Moxifloxacin, Sterile Ophthalmic Solution for Injection, Preservative Free, 0.8mg/0.8 mL (1mg/mL), 0.8 mL per syringe, Single Use Syringe, For Intraocular Injection, Edge Pharma, LL, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1050-01

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Mitomycin-C, Sterile Ophthalmic Solution, Preservative Free, 0.16mg/0.8mL (0.2 mg/mL), 0.8 mL per syringe, Single Use Syringe, For Topical Ophthalmic Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1011-01

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Mitomycin-C Sterile Ophthalmic Solution, Preservative Free, 0.32mg/0.8 mL (0.4mg/mL) 0.8 mL per syringe, Single Use Syringe, For Topical Ophthalmic Use, Edge Pharma LLC, 856 Hercules Dr. Colchester, VT 05446, NDC 05446-1009-01

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Mitomycin-C, 40mg/40mL (1mg/mL), 40 mL per syringe, Single Dose Syringe for Intravesical Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1416-01

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Methotrexate, USP, Sterile Solution for Injection (PF), 125 mg/5mL (2mg/mL), 5 mL per syringe, Edge Pharma, LLC, 856 Hercules Dr, Colchester, VT 05446, NDC 05446-1505-05

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Methacholine Challenge 5-Syringe Test Kit, Sterile Inhalation Solution, Preservative Free, 3 mL per syringe,(NDC 05446-1600-05), Kit includes; individual syringe: Methacholine Chloride,16 mg/mL (contains 48 mg) NDC 05446-1241-01; Methacholine Chloride 4 mg/mL (contains 12mg), NDC 05446-1246-01; Methacholine chloride 1mg/mL (contains 3 mg), NDC 05446-1247-01; Methacholine chloride 0.25mg/mL (contains 0.75mg), NDC 05446-1248-01; and Methacholine chloride 0.0625mg/mL NDC 05446-1249-01 Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Lidocaine HCL / Bupivacaine HCL (contains Hyaluronidase 15 units/mL), Sterile Ophthalmic Solution for Injection (PF), 2%/0.375%, 8 mL per syringe, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1548-18

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Gemcitabine, Sterile Intravesical Solution, Preservative Free, 1g/50mL (20 mg/mL), 50 mL per syringe, Single Dose Syringe for Intravesical Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1566-50

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Epinephrine/Lidocaine HCl Sterile Ophthalmic Solution for Injection, Preservative Free, 0.025%/0.75%, 0.8 mL per syringe, Single Use Syringe, For Intraocular Injection, Edge Pharma, LLC, 856 Hercules Dr. Colchester, VT 05446, NDC 05446-0863-01

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Edetate Disodium (EDTA), Sterile Ophthalmic Solution, (PF) 3%, 10mL per dropper, Single Dose Droptainer for Topical Ophthalmic Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT, 05446, NDC 05446-1428-10

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Edetate Disodium (EDTA), Sterile Ophthalmic Solution (PF) 1.5%, 10 mL per dropper, Single Dose Droptainer for Topical Ophthalmic Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT, 05446, NDC 05446-1427-10

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility.
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Dexamethasone sodium phosphate, sterile otic solution for injection Preservative free, 19.2 mg/0.8mL (24mg/mL), 0.8 mL per syringe Single Use Syringe For Otic Injection, Edge Pharma LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-0848-01

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Cefuroxime, Sterile Ophthalmic Solution for Injection, Preservative Free, 3mg/0.3mL (10 mg/mL), 0.3 mL single use syringe for Intraocular Injection, Edge Pharma, LLC, 656 Hercules Dr., Colchester, VT 05446 NDC 05446-1003-01

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Ceftazidime, Sterile Ophthalmic Solution for Injection, Preservative Free (11.25 mg/0.5 mL (22.5 mg/mL), 0.5mL single use syringe for Intraocular Injection, Edge Pharma, LLC, 656 Hercules Dr., Colchester, VT 05446, NDC 05446-0733-01

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Lidocaine HCl/Epinephrine, Sterile Buffered Solution for Injection (PF) 1% / 1:100,000, 3 mL per syringe, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, (802) 992-1178, NDC 05446-1268-01

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Lidocaine HCl Sterile Buffered Solution for Injection (PF) 1%, 10mL per syringe, Single Use Syringe for Infiltration and Nerve Block, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-0850-10

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

ALUM Concentrate (Aluminum Potassium Sulfate Dodecahydrate in Sterile Water (PF) 30 g/300 ml, IV bag, Rx Only, Edge Pharma, LLC, 856 Hercules Dr, Colchester, VT 05446, NDC 05446-0637-03

by Edge Pharma, LLC

Reason
Lack of Assurance of Sterility
Published
February 2, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: May 31, 2023Historical recordClass II

Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ, 07054, NDC 67877-590-01.

by Ascend Laboratories, LLC

Reason
Failed Dissolution Specifications.
Published
February 2, 2022
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.